跳至主要内容
临床试验/NCT05004662
NCT05004662已完成不适用

Partnering With a State Food Bank to Provide Tobacco Treatment to Underserved Smokers (Project NOURISH)

H. Lee Moffitt Cancer Center and Research Institute1 个研究点 分布在 1 个国家目标入组 502 人开始时间: 2021年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
502
试验地点
1
主要终点
Self-Reported 7-Day Point-Prevalence Smoking Abstinence

研究概览

简要总结

This study evaluates the efficacy and economic impact of a theoretically-based, fully automated, interactive smartphone-based smoking cessation intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •≥100 lifetime cigarettes
  • •English or Spanish speaking
  • •Currently smoke ≥5 cigarettes/day
  • •Process a smartphone compatible with the project app
  • •Have a valid email address
  • •Receipt of food assistance in the past 3 month

排除标准

  • •Currently pregnant or breastfeeding
  • •Current use of smoking cessation medications
  • •Enrolled in a smoking cessation study
  • •Household member enrolled in the study
  • •Failure to electronically confirm participation with 14 days of randomization via electronic link sent to participant's smartphone

研究组 & 干预措施

Standard Treatment

Active Comparator

Participants randomized to Standard Treatment (ST) were provided with a 10-week supply of nicotine patches and lozenges. ST participants were connected with their state's Quitline services to receive smoking cessation treatment.

干预措施: Nicotine patch (Drug)

Standard Treatment

Active Comparator

Participants randomized to Standard Treatment (ST) were provided with a 10-week supply of nicotine patches and lozenges. ST participants were connected with their state's Quitline services to receive smoking cessation treatment.

干预措施: Nicotine lozenge (Drug)

Automated Treatment

Experimental

Participants randomized to Automated Treatment (AT) were given a 10-week supply of nicotine patches and lozenges. AT comprised: 1) 12 proactive video-based treatment sessions, delivered weekly, that were tailored on smoking status, motivation, agency, and negative affect/stress; 2) 26 weeks of on-demand access to treatment content tailored on smoking status, motivation, agency, and negative affect/stress; 3) 26 weeks of text content.

干预措施: Smartphone-delivered automated treatment (Behavioral)

Automated Treatment

Experimental

Participants randomized to Automated Treatment (AT) were given a 10-week supply of nicotine patches and lozenges. AT comprised: 1) 12 proactive video-based treatment sessions, delivered weekly, that were tailored on smoking status, motivation, agency, and negative affect/stress; 2) 26 weeks of on-demand access to treatment content tailored on smoking status, motivation, agency, and negative affect/stress; 3) 26 weeks of text content.

干预措施: Nicotine patch (Drug)

Automated Treatment

Experimental

Participants randomized to Automated Treatment (AT) were given a 10-week supply of nicotine patches and lozenges. AT comprised: 1) 12 proactive video-based treatment sessions, delivered weekly, that were tailored on smoking status, motivation, agency, and negative affect/stress; 2) 26 weeks of on-demand access to treatment content tailored on smoking status, motivation, agency, and negative affect/stress; 3) 26 weeks of text content.

干预措施: Nicotine lozenge (Drug)

Standard Treatment

Active Comparator

Participants randomized to Standard Treatment (ST) were provided with a 10-week supply of nicotine patches and lozenges. ST participants were connected with their state's Quitline services to receive smoking cessation treatment.

干预措施: Counseling (Behavioral)

结局指标

主要结局

Self-Reported 7-Day Point-Prevalence Smoking Abstinence

时间窗: 12 Month Follow-Up

Participants who report no smoking, not even a puff, within the past 7 days

次要结局

  • Biochemical Verification Via Salivary Cotinine(12 Month Follow-Up)
  • Self-Reported 24-Hour Point-Prevalence Smoking Abstinence(12 Month Follow-Up)
  • Self-Reported 30-Day Point-Prevalence Smoking Abstinence(12 Month Follow-Up)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验